Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study

References

• Castelo-Branco C, Cancelo MJ, Villero J, et al. Management of post-menopausal vaginal atrophy and atrophic vaginitis. Maturitas 2005;52:46–52
   PubMed Web of Science ®Google Scholar
• MacBride MB, Rhodes DJ, Shuster LT. Vulvovaginal atrophy. Mayo Clin Proc 2010;85:87–94
   PubMed Web of Science ®Google Scholar
• Nappi RE, Palacios S. Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. Climacteric 2014;17:3–9
   PubMed Web of Science ®Google Scholar
• Portman DJ, Gass ML. Vulvovaginal atrophy terminology consensus conference panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the international society for the study of women’s sexual health and the North American Menopause Society. Climacteric 2014;17:557–63
   PubMed Web of Science ®Google Scholar
• Vieira-Baptista P, Marchitelli C, Haefner HK, Donders G, Pérez-López F. Deconstructing the genitourinary syndrome of menopause. Int Urogynecol J 2017;28:675–9
   PubMed Web of Science ®Google Scholar
• Palacios S, Castelo-Branco C, Currie H, et al. Update on management of genitourinary syndrome of menopause: a practical guide. Maturitas 2015;82:308–13
   PubMed Web of Science ®Google Scholar
• Van Geelen JM, van de Weijer PH, Arnolds HT. Urogenital symptoms and resulting discomfort in non-institutionalized Dutch women aged 50-75 years. Int Urogynecol J Pelvic J 2000;11:9–14
   PubMed Web of Science ®Google Scholar
• Pastore LM, Carter RA, Hulka BS, et al. Self-reported urogenital symptoms in postmenopausal women: women’s health initiative. Maturitas 2004;49:292–303
   PubMed Web of Science ®Google Scholar
• Jackson SL, Boyko EJ, Scholes D, et al. Predictors of urinary tract infection after menopause: a prospective study. Am J Med 2004;117:903–11
   PubMed Web of Science ®Google Scholar
• Oskay UY, Beji NK, Yalcin O. A study on urogenital complaints of postmenopausal women aged 50 and over. Acta Obstet Gynecol Scand 2005;84:72–8
   PubMed Web of Science ®Google Scholar
• Valadares AL, Pinto-Neto AM, Conde DM, et al. A population-based study of dyspareunia in a cohort of middle-aged Brazilian women. Menopause 2008;15:1184–90
   PubMed Web of Science ®Google Scholar
• Edwards D, Panay N. Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition? Climacteric 2016;19:151–61
   PubMed Web of Science ®Google Scholar
• Sturdee DW, Panay N. International Menopause Society Writing Group. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 2010;13:509–22
   PubMed Web of Science ®Google Scholar
• Cardozo L, Bachmann G, McClish D, et al. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the hormones and urogenital therapy committee. Obstet Gynecol 1998;92:722–7
   PubMed Web of Science ®Google Scholar
• Palacios S. Managing urogenital atrophy. Maturitas 2009;63:315–18
   PubMed Web of Science ®Google Scholar
• Prairie BA, Klein-Patel M, Lee M, et al. What midlife women want from gynecologists: a survey of patients in specialty and private practices. J Womens Health (Larchmt) 2014;23:513–18
   PubMed Web of Science ®Google Scholar
• Cano A, Estévez J, Usandizaga R, et al. The therapeutic effect of a new ultralow concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from. a Pivotal Phase III Study. Menopause 2012;19:1130–9
   PubMed Web of Science ®Google Scholar
• Goldstein I, Dicks B, Kim NN, et al. Multidisciplinary overview of vaginal atrophy and associated genitourinary symptoms in postmenopausal women. Sex Med 2013;1:44–53
   PubMed Web of Science ®Google Scholar
• Rahn DD, Carberry C, Sanses TV, et al. Vaginal estrogen for genitourinary syndrome of menopause: a systematic review. Obstet Gynecol 2014;124:1147–56
   PubMed Web of Science ®Google Scholar
• Nappi RE, Kokot-Kierepa M. Women’s voices in the menopause: results from an international survey on vaginal atrophy. Maturitas 2010;67:233–8
   PubMed Web of Science ®Google Scholar
• Parish SJ, Nappi RE, Krychman ML, et al. Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy. Int J Womens Health 2013;5:437–47
   PubMedGoogle Scholar
• Guidance for Industry [webpage on the Internet]. Estrogen and estrogen/progestin drug products to treat vasomotor symptoms and vulvar and vaginal atrophy symptoms – Recommendations for Clinical Evaluation. Food and Drug Administration; 2003. Available from: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatory-information/guidances/ucm071643.pdf [last accessed 16 Oct 2017]
   Google Scholar
• Huang AJ, Gregorich SE, Kuppermann M, et al. Day-to-day impact of vaginal aging questionnaire: a multidimensional measure of the impact of vaginal symptoms on functioning and well-being in postmenopausal women. Menopause 2015;22:144–54
   PubMed Web of Science ®Google Scholar
• Palma F, Volpe A, Villa P, et al. Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: the AGATA study. Maturitas 2016;83:40–4
   PubMed Web of Science ®Google Scholar
• Leiblum SR, Hayes RD, Wanser RA, et al. Vaginal dryness: a comparison of prevalence and interventions in 11 countries. J Sex Med 2009;6:2425–33
   PubMed Web of Science ®Google Scholar
• Kim HK, Kang SY, Chung YJ, et al. The recent review of the genitourinary syndrome of menopause. J Menopausal Med 2015;21:65–71
   PubMedGoogle Scholar
• Kingsberg SA, Wysocki S, Magnus L, et al. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (Real women’s Views of treatment options for menopausal vaginal changes) survey. J Sex Med 2013;10:1790–9
   PubMed Web of Science ®Google Scholar
• Nappi RE, Palacios S, Panay N, et al. Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey. Climacteric 2016;19:188–97
   PubMed Web of Science ®Google Scholar
• Genazzani AR, Schneider HPG, Panay N, et al. The European menopause survey 2005: Women’s perceptions on the menopause and postmenopause hormone therapy. Gynecol Endocrinol 2006;22:369–75
   PubMed Web of Science ®Google Scholar
• Grabe M, Bartoletti R, Bjerklund-Johansen TE, et al. Guidelines on urological infections, 2014. Available from: https://uroweb.org/wp-content/uploads/19-Urological-infections_LR.pdf
   Google Scholar
• Barlow DH, Cardozo LD, Francis RM, et al. Urogenital ageing and its effect on sexual health in older British women. Br J Obstet Gynaecol 1997;104:87–91
   PubMedGoogle Scholar
• Nappi RE, Kokot-Kierepa M. Vaginal health: insights, views & attitudes (VIVA) - results from an international survey. Climacteric 2012;15:36–44
   PubMed Web of Science ®Google Scholar
• Iosif CS, Bekassy Z. Prevalence of genito-urinary symptoms in the late menopause. Acta Obstet Gynecol Scand 1984;63:257–60
   PubMed Web of Science ®Google Scholar
• Molander U, Milsom I, Ekelund P, et al. An epidemiological study of urinary incontinence and related urogenital symptoms in elderly women. Maturitas 1990;12:51–60
   PubMed Web of Science ®Google Scholar
• Robinson D, Cardozo L. The pathophysiology and management of postmenopausal urogenital oestrogen deficiency. J Br Menopause Soc 2001;7:67–73
   Google Scholar
• Kodner CM, Thomas Gupton EK. Recurrent urinary tract infections in women: diagnosis and management. Am Fam Physician 2010;82:638–43
   PubMed Web of Science ®Google Scholar
• Nappi RE, Kingsberg S, Maamari R, et al. The CLOSER (CLarifying Vaginal Atrophy’s Impact On SEx and Relationships) survey: implications of vaginal discomfort in postmenopausal women and in male partners. J Sex Med 2013;10:2232–41
   PubMed Web of Science ®Google Scholar